Deutsche Bank AG vs Herbalife Nutrition Ltd — how do they compare? Deutsche Bank AG trades at $38.48 (market cap $71.96B), while Herbalife Nutrition Ltd trades at $11.77 (market cap $1.23B). The key difference: Deutsche Bank AG is far larger — about 58.5× Herbalife Nutrition Ltd's market cap, and Deutsche Bank AG pays a 3.04% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| DB | HLF | |
|---|---|---|
Market Cap | $71.96B | $1.23B |
Sector | Financials | Consumer Staples |
52-Week High | $40.33 | $19.96 |
52-Week Low | $28.37 | $7.75 |
Dividend Yield | 3.04% | — |
Enterprise Value | — | $3.06B |
Signals from Pluang's Aura AI — not financial advice
Deutsche Bank (DB) trades at $38.44, up 0.44% with a bullish technical signal. The stock shows strong fundamentals with a P/E of 10.07 and P/B of 0.79, trading at a discount to book value. Recent Q2 2026 earnings missed expectations ($0.66 vs. $0.91) but the company maintains strong capital buffers and announced a new share buyback program. Revenue growth continues with 2025 revenue reaching $32.1B and net income of $6.93B, representing a 21.59% margin.
The outlook remains positive with the bank positioned as a European alternative for AI dealmaking and recent designation as China's renminbi clearing bank creating growth opportunities. However, ongoing tax investigations and mixed analyst sentiment (57.58% hold rating) present near-term risks. The combination of discounted valuation and strategic positioning offers potential upside if execution continues.
HLF trades at $11.71, up 1.65% on the day, with a bearish technical signal from moving averages. The company shows mixed earnings, missing Q2 2026 EPS estimates but achieving four consecutive quarters of sales growth. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24, though negative shareholder equity and high debt levels present financial risks. Recent news includes a planned CFO transition and inclusion in TIME's America's Best Companies 2026 list.
The outlook for HLF balances low valuation against operational and financial challenges. Investment opportunity lies in potential margin improvement and debt reduction, but risks include earnings volatility, high leverage, and competitive pressures in the nutrition space. Analyst sentiment is cautiously optimistic with a majority buy rating.
Trailing returns across standard periods
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →